8 / 21
allied
academies
Page 55
Notes:
May 16-17, 2019 | Prague, Czech Republic
2
nd
International Conference on
22
nd
International Conference on
Nanomaterials and Nanotechnology
Advanced Nanoscience and Nanotechnology
Joint Event
&
Journal of Materials Science and Nanotechnology | Volume 3
Mater Sci Nanotechnol, Volume 3
Nanomedicine in the treatment of glioblastomas and neurological disorders
Alain L Fymat
International Institute of Medicine and Science, USA
O
ne of the most promising applications of nanomedicine
principles is in clinical neuroscience, particularly in
the treatment of glioblastomas and neurological disorders
(epilepsy, Parkinson disease; Alzheimer disease, etc.). Here,
specially-designed nanoparticles (NPs) delivered by specially-
designed nanocarriers are able to cross the blood brain
barrier to deliver their payload at pre-defined location(s)
according to specified time- and dose-fractionations while
remaining unnoticed by the immune system. I will discuss
the several NPs utilized and their corresponding clinical
advantages, including: Nutshells (that can be targeted to
bond to cancerous cells by conjugated antibodies or peptides
to anopheles' surfaces); platelet-coated NPs (that can deliver
higher doses of medication drugs to targeted sites, thus
greatly enhancing their therapeutic effects); biocompatible
and biodegradable gelatin NPs (that can deliver multiple
drugs); and shape-shifting engineered NPs (that can can be
tailored to deliver drugs to specified tumors and nowhere
else).
e
:
alain.fymat@fiimas.org